Vitiligo: A Review
The DOI matches its Crossref record; 270 of the 270 references it cites were found in a registry or an index.
Abstract
Vitiligo, a common depigmenting skin disorder, has an estimated prevalence of 0.5–2% of the population worldwide. The disease is characterized by the selective loss of melanocytes which results in typical nonscaly, chalky-white macules. In recent years, considerable progress has been made in our understanding of the pathogenesis of vitiligo which is now clearly classified as an autoimmune disease. Vitiligo is often dismissed as a cosmetic problem, although its effects can be psychologically devastating, often with a considerable burden on daily life. In 2011, an international consensus classified segmental vitiligo separately from all other forms of vitiligo, and the term vitiligo was defined to designate all forms of nonsegmental vitiligo. This review summarizes the current knowledge on vitiligo and attempts to give an overview of the future in vitiligo treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Data on the incidence of vitiligo are scarce; in Europe, the prevalence rate of diagnosed vitiligo ranges from 0.2% to 0.8%, with geographical and methodological differences. 1,3,4”
From Burden of disease and treatment patterns in patients with vitiligo: findings from a national longitudinal retrospective study in the UK (2024) · cites this paper as [1]
In the citing paper
“Data on the incidence of vitiligo are scarce; in Europe, the prevalence rate of diagnosed vitiligo ranges from 0.2% to 0.8%, with geographical and methodological differences. 1,3,4”
From Burden of disease and treatment patterns in patients with vitiligo: findings from a national longitudinal retrospective study in the UK (2024) · cites this paper as [1]
Citations
Cites
WARE, J. E., KOSINSKI, M., & KELLER, S. D. (1996) · Medical Care · doi:10.1097/00005650-199603000-00003 · Cited by 17,392
Oxidative Stress in the Pathogenesis of Skin Disease
Bickers, D. R., & Athar, M. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700340 · Cited by 1,092
Ezzedine, K., Eleftheriadou, V., Whitton, M., & van Geel, N. (2015) · The Lancet · doi:10.1016/s0140-6736(14)60763-7 · Cited by 943
Self-citationEpidemiology of Vitiligo and Associated Autoimmune Diseases in Caucasian Probands and Their Families
Alkhateeb, A., Fain, P. R., Thody, A., Bennett, D. C., & Spritz, R. A. (2003) · Pigment Cell Research · doi:10.1034/j.1600-0749.2003.00032.x · Cited by 728
Vitiligo: A comprehensive overview
Alikhan, A., Felsten, L. M., Daly, M., & Petronic-Rosic, V. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.11.061 · Cited by 708
Ezzedine, K., Lim, H. W., Suzuki, T., Katayama, I., Hamzavi, I., Lan, C. C. E., Goh, B. K., Anbar, T., Silva de Castro, C., Lee, A. Y., et al. (2012) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2012.00997.x · Cited by 702
Self-citationType I/II cytokines, JAKs, and new strategies for treating autoimmune diseases
Schwartz, D. M., Bonelli, M., Gadina, M., & O'Shea, J. J. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.167 · Cited by 648
NALP1 in Vitiligo-Associated Multiple Autoimmune Disease
Jin, Y., Mailloux, C. M., Gowan, K., Riccardi, S. L., LaBerge, G., Bennett, D. C., Fain, P. R., & Spritz, R. A. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061592 · Cited by 630
A review of the worldwide prevalence of vitiligo in children/adolescents and adults
Krüger, C., & Schallreuter, K. U. (2012) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2011.05377.x · Cited by 571
Autoimmune Destruction of Skin Melanocytes by Perilesional T Cells from Vitiligo Patients
van den Boorn, J. G., Konijnenberg, D., Dellemijn, T. A. M., Wietze van der Veen, J. P., Bos, J. D., Melief, C. J. M., Vyth-Dreese, F. A., & Luiten, R. M. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.32 · Cited by 543
Rashighi, M., Agarwal, P., Richmond, J. M., Harris, T. H., Dresser, K., Su, M.-W., Zhou, Y., Deng, A., Hunter, C. A., Luster, A. D., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007811 · Cited by 518
The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force
Taïeb, A., Picardo, M., & members, O. B. O. T. O. V. (2007) · Pigment Cell Research · doi:10.1111/j.1600-0749.2006.00355.x · Cited by 517
New discoveries in the pathogenesis and classification of vitiligo
Rodrigues, M., Ezzedine, K., Hamzavi, I., Pandya, A. G., & Harris, J. E. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.10.048 · Cited by 476
Self-citationHigh Frequency of Skin-homing Melanocyte-specific Cytotoxic T Lymphocytes in Autoimmune Vitiligo
Ogg, G. S., Rod Dunbar, P., Romero, P., Chen, J.-L., & Cerundolo, V. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.6.1203 · Cited by 460
Taieb, A., Alomar, A., Böhm, M., Dell’Anna, M. L., De Pase, A., Eleftheriadou, V., Ezzedine, K., Gauthier, Y., Gawkrodger, D. J., Jouary, T., et al. (2013) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.11197.x · Cited by 450
Self-citationVega, V. L., Rodríguez-Silva, M., Frey, T., Gehrmann, M., Diaz, J. C., Steinem, C., Multhoff, G., Arispe, N., & De Maio, A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.6.4299 · Cited by 449
Evidence for an Autoimmune Pathogenesis of Vitiligo
Ongenae, K., Van Geel, N., & Naeyaert, J. (2003) · Pigment Cell Research · doi:10.1034/j.1600-0749.2003.00023.x · Cited by 437
Melanocytes as Instigators and Victims of Oxidative Stress
Denat, L., Kadekaro, A. L., Marrot, L., Leachman, S. A., & Abdel-Malek, Z. A. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.65 · Cited by 416
Variant of TYR and Autoimmunity Susceptibility Loci in Generalized Vitiligo
Jin, Y., Birlea, S. A., Fain, P. R., Gowan, K., Riccardi, S. L., Holland, P. J., Mailloux, C. M., Sufit, A. J. D., Hutton, S. M., Amadi-Myers, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908547 · Cited by 415
Self-citationHarris, J. E., Harris, T. H., Weninger, W., John Wherry, E., Hunter, C. A., & Turka, L. A. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.463 · Cited by 389
Jin, Y., Andersen, G., Yorgov, D., Ferrara, T. M., Ben, S., Brownson, K. M., Holland, P. J., Birlea, S. A., Siebert, J., Hartmann, A., et al. (2016) · Nature Genetics · doi:10.1038/ng.3680 · Cited by 355
Self-citationGenome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo
Jin, Y., Birlea, S. A., Fain, P. R., Ferrara, T. M., Ben, S., Riccardi, S. L., Cole, J. B., Gowan, K., Holland, P. J., Bennett, D. C., et al. (2012) · Nature Genetics · doi:10.1038/ng.2272 · Cited by 353
Self-citationLow Catalase Levels in the Epidermis of Patients with Vitiligo
Schallreuter, K. U., Wood, J. M., & Berger, J. (1991) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12492612 · Cited by 347
Guideline for the diagnosis and management of vitiligo
Gawkrodger, D. J., Ormerod, A. D., Shaw, L., Mauri-Sole, I., Whitton, M. E., Watts, M. J., Anstey, A. V., Ingham, J., & Young, K. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08881.x · Cited by 332
Picardo, M., Dell'Anna, M. L., Ezzedine, K., Hamzavi, I., Harris, J. E., Parsad, D., & Taieb, A. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.11 · Cited by 326
Self-citationMaresca, V., Roccella, M., Roccella, F., Camera, E., Del Porto, G., Passi, S., Grammatico, P., & Picardo, M. (1997) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12335801 · Cited by 302
Quality of life in patients with vitiligo.
Parsad, D., Dogra, S., & Kanwar, A. J. (2003) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-1-58 · Cited by 301
Lerner, A. B. (1959) · Journal of Investigative Dermatology · doi:10.1038/jid.1959.49 · Cited by 297
The Prevalence of Vitiligo: A Meta-Analysis
Zhang, Y., Cai, Y., Shi, M., Jiang, S., Cui, S., Wu, Y., Gao, X.-H., & Chen, H.-D. (2016) · PLOS ONE · doi:10.1371/journal.pone.0163806 · Cited by 292
Poole, I. C. L., van den Wijngaard, R. M., Westerhof, W., & Das, P. K. (1996) · Europe PMC (PubMed Central) · Cited by 282
Local Immune Response in Skin of Generalized Vitiligo Patients
van den Wijngaard, R., Wankowicz-Kalinska, A., Le Poole, C., Tigges, B., Westerhof, W., & Das, P. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780138 · Cited by 272
Review of the etiopathomechanism of vitiligo: A convergence theory
Le Poole, I. C., Das, P. K., van den Wijngaard, R. M. J. G. J., Bos, J. D., & Westerhof, W. (1993) · Experimental Dermatology · doi:10.1111/j.1600-0625.1993.tb00023.x · Cited by 268
Vitiligo Skin Is Imprinted with Resident Memory CD8 T Cells Expressing CXCR3
Boniface, K., Jacquemin, C., Darrigade, A.-S., Dessarthe, B., Martins, C., Boukhedouni, N., Vernisse, C., Grasseau, A., Thiolat, D., Rambert, J., et al. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.08.038 · Cited by 263
Self-citationWańkowicz-Kalińska, A., van den Wijngaard, R. M. J. G. J., Tigges, B. J., Westerhof, W., Ogg, G. S., Cerundolo, V., Storkus, W. J., & Das, P. K. (2003) · Laboratory Investigation · doi:10.1097/01.lab.0000069521.42488.1b · Cited by 262
Tofacitinib Citrate for the Treatment of Vitiligo: A Pathogenesis-Directed Therapy
Craiglow, B. G., & King, B. A. (2015) · JAMA Dermatology · doi:10.1001/jamadermatol.2015.1520 · Cited by 259
Jimbow, K., Chen, H., Park, J.-S., & Thomas, P. D. (2001) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2001.03952.x · Cited by 253
Targeting the Janus Kinase Family in Autoimmune Skin Diseases
Howell, M. D., Kuo, F. I., & Smith, P. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02342 · Cited by 251
Vitiligo: Compendium of clinico-epidemiological features
Sehgal, V., & Srivastava, G. (2007) · Indian Journal of Dermatology, Venereology and Leprology · doi:10.4103/0378-6323.32708 · Cited by 250
Segmental vitiligo: Clinical findings in 208 patients
Hann, S. K., & Lee, H. J. (1996) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(96)90718-5 · Cited by 246
Phototherapy for Vitiligo: A Systematic Review and Meta-analysis
Bae, J. M., Jung, H. M., Hong, B. Y., Lee, J. H., Choi, W. J., Lee, J. H., & Kim, G. M. (2017) · JAMA Dermatology · doi:10.1001/jamadermatol.2017.0002 · Cited by 242
Richmond, J. M., Bangari, D. S., Essien, K. I., Currimbhoy, S. D., Groom, J. R., Pandya, A. G., Youd, M. E., Luster, A. D., & Harris, J. E. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.09.016 · Cited by 235
Innate immune mechanisms in vitiligo: danger from within
Richmond, J. M., Frisoli, M. L., & Harris, J. E. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.10.010 · Cited by 225
Vitiligo: How do oxidative stress-induced autoantigens trigger autoimmunity?
Xie, H., Zhou, F., Liu, L., Zhu, G., Li, Q., Li, C., & Gao, T. (2016) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2015.09.003 · Cited by 214
The burden of vitiligo: Patient characteristics associated with quality of life
Linthorst Homan, M. W., Spuls, P. I., de Korte, J., Bos, J. D., Sprangers, M. A., & van der Veen, J. P. W. (2009) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.03.022 · Cited by 214
Papadopoulos, L., Bor, R., & Legg, C. (1999) · British Journal of Medical Psychology · doi:10.1348/000711299160077 · Cited by 212
Ralf Paus, L., Schallreuter, K. U., Bahadoran, P., Picardo, M., Slominski, A., Elassiuty, Y. E., Kemp, E. H., Giachino, C., Liu, J. B., Luiten, R. M., et al. (2008) · Experimental Dermatology · doi:10.1111/j.1600-0625.2007.00666_1.x · Cited by 211
Spritz, R. A., & Andersen, G. H. L. (2017) · Dermatologic Clinics · doi:10.1016/j.det.2016.11.013 · Cited by 207
Norris, D. A., Kissinger, R. M., Naughton, G. M., & Bystryn, J. C. (1988) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12461505 · Cited by 205
Toosi, S., Orlow, S. J., & Manga, P. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.181 · Cited by 203
A Systematic Review of Autologous Transplantation Methods in Vitiligo
Njoo, M. D., Westerhof, W., Bos, J. D., & Bossuyt, P. M. M. (1998) · Archives of Dermatology · doi:10.1001/archderm.134.12.1543 · Cited by 202
Yang, L., Wei, Y., Sun, Y., Shi, W., Yang, J., Zhu, L., & Li, M. (2015) · Acta Dermato Venereologica · doi:10.2340/00015555-2080 · Cited by 199
Melanocyte detachment after skin friction in non lesional skin of patients with generalized vitiligo
Gauthier, Y., Cario-Andre, M., Lepreux, S., Pain, C., & Taieb, A. (2003) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2003.05024.x · Cited by 199
Harris, J. E., Rashighi, M., Nguyen, N., Jabbari, A., Ulerio, G., Clynes, R., Christiano, A. M., & Mackay-Wiggan, J. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.09.073 · Cited by 199
Current and emerging treatments for vitiligo
Rodrigues, M., Ezzedine, K., Hamzavi, I., Pandya, A. G., & Harris, J. E. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.11.010 · Cited by 196
Self-citationPrevalence of Vitiligo: Epidemiological Survey on the Isle of Bornholm, Denmark
Howitz, J. (1977) · Archives of Dermatology · doi:10.1001/archderm.1977.01640010049006 · Cited by 194
Cellular and developmental aspects of androgenetic alopecia
Jahoda, C. A. B. (1998) · Experimental Dermatology · doi:10.1111/j.1600-0625.2007.00666.x · Cited by 192
Psychosocial effects of vitiligo
Ongenae, K., Beelaert, L., van Geel, N., & Naeyaert, J. (2006) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2005.01369.x · Cited by 192
Wang, X. X., Wang, Q. Q., Wu, J. Q., Jiang, M., Chen, L., Zhang, C. F., & Xiang, L. H. (2016) · British Journal of Dermatology · doi:10.1111/bjd.14416 · Cited by 191
Pattern of Familial Aggregation of Vitiligo
Majumder, P. P. (1993) · Archives of Dermatology · doi:10.1001/archderm.1993.01680290066010 · Cited by 189
Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib
Rothstein, B., Joshipura, D., Saraiya, A., Abdat, R., Ashkar, H., Turkowski, Y., Sheth, V., Huang, V., Au, S. C., Kachuk, C., et al. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2017.02.049 · Cited by 189
Lim, H. W., Grimes, P. E., Agbai, O., Hamzavi, I., Henderson, M., Haddican, M., Linkner, R. V., & Lebwohl, M. (2015) · JAMA Dermatology · doi:10.1001/jamadermatol.2014.1875 · Cited by 188
Development and validation of a vitiligo-specific quality-of-life instrument (VitiQoL)
Lilly, E., Lu, P. D., Borovicka, J. H., Victorson, D., Kwasny, M. J., West, D. P., & Kundu, R. V. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2012.01.038 · Cited by 187
Vitiligo and Other Diseases: Coexistence or True Association?
Schallreuter, K. U., Lemke, R., Brandt, O., Schwartz, R., Westhofen, M., Montz, R., & Berger, J. (1994) · Dermatology · doi:10.1159/000247164 · Cited by 186
Reduced skin homing by functional Treg in vitiligo: Absence of Treg in vitiligo skin
Klarquist, J., Denman, C. J., Hernandez, C., Wainwright, D. J., Strickland, F. M., Overbeck, A., Mehrotra, S., Nishimura, M. I., & Le Poole, I. C. (2010) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2010.00688.x · Cited by 176
Effectiveness of oral Ginkgo biloba in treating limited, slowly spreading vitiligo
Parsad, D., Pandhi, R., & Juneja, A. (2003) · Clinical and Experimental Dermatology · doi:10.1046/j.1365-2230.2003.01207.x · Cited by 176
Kroll, T. M., Bommiasamy, H., Boissy, R. E., Hernandez, C., Nickoloff, B. J., Mestril, R., & Caroline Le Poole, I. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23653.x · Cited by 175
Njoo, M. D., Vodegel, R. M., & Westerhof, W. (2000) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2000.103813 · Cited by 174
Vitiligo and depression: a systematic review and meta‐analysis of observational studies
Lai, Y. C., Yew, Y. W., Kennedy, C., & Schwartz, R. A. (2017) · British Journal of Dermatology · doi:10.1111/bjd.15199 · Cited by 174
A review and a new hypothesis for non‐immunological pathogenetic mechanisms in vitiligo
Dell'Anna, M. L., & Picardo, M. (2006) · Pigment Cell Research · doi:10.1111/j.1600-0749.2006.00333.x · Cited by 173
Immunopathogenesis of vitiligo
Sandoval-Cruz, M., García-Carrasco, M., Sánchez-Porras, R., Mendoza-Pinto, C., Jiménez-Hernández, M., Munguía-Realpozo, P., & Ruiz-Argüelles, A. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.02.004 · Cited by 172
Th17 Cells and Activated Dendritic Cells Are Increased in Vitiligo Lesions
Wang, C. Q. F., Cruz-Inigo, A. E., Fuentes-Duculan, J., Moussai, D., Gulati, N., Sullivan-Whalen, M., Gilleaudeau, P., Cohen, J. A., & Krueger, J. G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018907 · Cited by 169
Autoimmunity as an aetiological factor in vitiligo
Rezaei, N., Gavalas, N., Weetman, A., & Kemp, E. (2007) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2007.02228.x · Cited by 166
Wagner, R. Y., Luciani, F., Cario-André, M., Rubod, A., Petit, V., Benzekri, L., Ezzedine, K., Lepreux, S., Steingrimsson, E., Taieb, A., et al. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.25 · Cited by 166
Self-citationMiddelkamp‐Hup, M., Bos, J., Rius‐Diaz, F., Gonzalez, S., & Westerhof, W. (2007) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2006.02132.x · Cited by 165
PASRICHA, J. S., & KHAITAN, B. K. (1993) · International Journal of Dermatology · doi:10.1111/j.1365-4362.1993.tb02754.x · Cited by 164
Genetic epidemiology of vitiligo: multilocus recessivity cross-validated.
Nath, S. K., Majumder, P. P., & Nordlund, J. J. (1994) · PubMed · Cited by 163
van den Boorn, J. G., Picavet, D. I., van Swieten, P. F., van Veen, H. A., Konijnenberg, D., van Veelen, P. A., van Capel, T., de Jong, E. C., Reits, E. A., Drijfhout, J. W., et al. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.16 · Cited by 160
Type I interferon signature in the initiation of the immune response in vitiligo
Bertolotti, A., Boniface, K., Vergier, B., Mossalayi, D., Taieb, A., Ezzedine, K., & Seneschal, J. (2014) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12219 · Cited by 160
Self-citationHasse, S., Gibbons, N. C. J., Rokos, H., Marles, L. K., & Schallreuter, K. U. (2004) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2004.22230.x · Cited by 157
Six Decades of Vitiligo Genetics: Genome-Wide Studies Provide Insights into Autoimmune Pathogenesis
Spritz, R. A. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.321 · Cited by 154
Superimposed segmental manifestation of polygenic skin disorders
Happle, R. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2007.06.039 · Cited by 150
Vitiligo is not a cosmetic disease
Ezzedine, K., Sheth, V. M., Rodrigues, M. A., Eleftheriadou, V., Harris, J. E., Hamzavi, I. H., & Pandya, A. G. (2015) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.07.039 · Cited by 149
Self-citationQuality of Life, Burden of Disease, Co-morbidities, and Systemic Effects in Vitiligo Patients
Elbuluk, N., & Ezzedine, K. (2017) · Dermatologic Clinics · doi:10.1016/j.det.2016.11.002 · Cited by 149
Self-citationvan Geel, N., Ongenae, K., Mil, M. D., et al. (2004) · Archives of Dermatology · doi:10.1001/archderm.140.10.1203 · Cited by 147
Koebner’s phenomenon in vitiligo: European position paper
van Geel, N., Speeckaert, R., Taïeb, A., Picardo, M., Böhm, M., Gawkrodger, D. J., Schallreuter, K. U., Bennett, D. C., van der Veen, W., Whitton, M. E., et al. (2011) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2011.00838.x · Cited by 147
Self-citationCombined Excimer Laser and Topical Tacrolimus for the Treatment of Vitiligo: A Pilot Study
Kawalek, A. Z., SPENCER, J. M., & Phelps, R. G. (2004) · Dermatologic Surgery · doi:10.1111/j.1524-4725.2004.30058.x · Cited by 147
Psychological reaction to chronic skin disorders
Porter, J. R., Beuf, A. H., Nordlund, J. J., & Lerner, A. B. (1979) · General Hospital Psychiatry · doi:10.1016/0163-8343(79)90081-1 · Cited by 146
Clinical features and course of type A and type B vitiligo
Koga, M., & Tango, T. (1988) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1988.tb01778.x · Cited by 146
Birlea, S. A., Jin, Y., Bennett, D. C., Herbstman, D. M., Wallace, M. R., McCormack, W. T., Kemp, E. H., Gawkrodger, D. J., Weetman, A. P., Picardo, M., et al. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.337 · Cited by 143
Self-citationMitochondrial Impairment in Peripheral Blood Mononuclear Cells During the Active Phase of Vitiligo
Dell’Anna, M. L., Maresca, V., Briganti, S., Camera, E., Picardo, M., & Falchi, M. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01459.x · Cited by 143
Morrone, A., Picardo, M., Luca, C. D., TERMINALI, O., Passi, S., & IPPOLITO, F. (1992) · Pigment Cell Research · doi:10.1111/j.1600-0749.1992.tb00003.x · Cited by 142
Mutant HSP70 Reverses Autoimmune Depigmentation in Vitiligo
Mosenson, J. A., Zloza, A., Nieland, J. D., Garrett-Mayer, E. S., Eby, J. M., Huelsmann, E. J., Kumar, P., Denman, C. J., Lacek, A. T., Kohlhapp, F. J., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005127 · Cited by 142
Yu, R., Broady, R. C., Huang, Y., Wang, Y., Yu, J., Gao, M., Levings, M. K., Wei, S., Zhang, S., Xu, A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051040 · Cited by 140
Mohammad, T. F., Al-Jamal, M., Hamzavi, I. H., Harris, J. E., Leone, G., Cabrera, R., Lim, H. W., Pandya, A. G., & Esmat, S. M. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.12.041 · Cited by 138
Studies on vitiligo I. Epidemiological profile in Calcutta, India
Das, S., Majumder, P. P., Chakrabotry, R., Majumdar, T. K., Haldar, B., & Rao, D. C. (1985) · Genetic Epidemiology · doi:10.1002/gepi.1370020107 · Cited by 136
Detection of Antibodies to Melanocytes in Vitiligo by Specific Immunoprecipitation
Naughton, G. K., Eisinger, M., & Bystryn, J. (1983) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12522891 · Cited by 136
Regulatory T cells in vitiligo: Implications for pathogenesis and therapeutics
Dwivedi, M., Kemp, E. H., Laddha, N. C., Mansuri, M. S., Weetman, A. P., & Begum, R. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.10.002 · Cited by 135
Chen, Y.-F., Yang, P., Hu, D., et al. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2003.12.013 · Cited by 135
Tyrosinase as an autoantigen in patients with vitiligo
Baharav, E., Merimski, O., Shoenfeld, Y., et al. (1996) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1996.d01-727.x · Cited by 132
Nevus depigmentosus: Clinical features and histopathologic characteristics in 67 patients
Lee, H., Chun, Y., & Hann, S. (1999) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(99)70524-4 · Cited by 132
Rao, G. R., Rao, A. D., Moorthy, B., Rao, T., Sravani, P., Babu, N. K., & Gopal, K. V. T. (2009) · Indian Journal of Dermatology Venereology and Leprology · doi:10.4103/0378-6323.48427 · Cited by 131
Salzes, C., Abadie, S., Sénéschal, J., Whitton, M. E., Meurant, J. ‐., Jouary, T., Ballanger, F., Boralévi, F., Taı̈eb, A., TAIEB, C., et al. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.398 · Cited by 131
Self-citationThulasingam, S., Massilamany, C., Gangaplara, A., Dai, H., Yarbaeva, S., Subramaniam, S., Riethoven, J.-J. M., Eudy, J. D., Lou, M. F., & Reddy, J. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-0752-2 · Cited by 128
Childhood- and later-onset vitiligo have diverse epidemiologic and clinical characteristics
Nicolaidou, E., Antoniou, C., Miniati, A., et al. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2011.07.010 · Cited by 126
Treatment Outcomes of Topical Calcineurin Inhibitor Therapy for Patients With Vitiligo
Lee, J. H., Kwon, H. S., Jung, H. M., Lee, H., Kim, G. M., Yim, H. W., & Bae, J. M. (2019) · JAMA Dermatology · doi:10.1001/jamadermatol.2019.0696 · Cited by 126
Shen, C., Gao, J., Sheng, Y., Dou, J., Zhou, F., Zheng, X., Ko, R., Tang, X., Zhu, C., Yin, X., et al. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00003 · Cited by 122
Kakourou, T., Kanaka‐Gantenbein, C., Papadopoulou, A., Kaloumenou, E., & Chrousos, G. P. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2005.03.032 · Cited by 119
An epidemiologic case-control study in a population with vitiligo
Barona, M. I., Arrunátegui, A., Rafael Falabella, F., & Alzate, A. (1995) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(95)91282-7 · Cited by 119
Osinubi, O., Grainge, M. J., Hong, L., Ahmed, A., Batchelor, J., Grindlay, D. J. C., Thompson, A. R., & Ratib, S. (2017) · British Journal of Dermatology · doi:10.1111/bjd.16049 · Cited by 119
Clinical profiles of vitiligo in China: an analysis of 3742 patients
Liu, J.-B., Li, M., Yang, S., et al. (2005) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2005.01813.x · Cited by 118
Oiso, N., Fukai, K., Kawada, A., & Suzuki, T. (2012) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2012.01583.x · Cited by 116
Topically Administered Fluorouracil in Vitiligo
Tsuji, T. (1983) · Archives of Dermatology · doi:10.1001/archderm.1983.01650330014006 · Cited by 115
Harris, J. E. (2015) · Immunological Reviews · doi:10.1111/imr.12369 · Cited by 115
Surgical interventions for vitiligo: an evidence-based review
Mulekar, S. V., & Isedeh, P. N. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12532 · Cited by 113
Kostopoulou, P., Jouary, T., Quintard, B., Ezzedine, K., Marques, S., Boutchneï, S., & Taı̈eb, A. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2009.09077.x · Cited by 113
Self-citationDirect Evidence to Support the Role of Antigen-Specific CD8+ T Cells in Melanoma-Associated Vitiligo
Gal, F. L., Lefebvre, P., Deschemin, J., Andrieu, M., Guillet, J., Avril, M., Bosq, J., & Dore, M.-X. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01605.x · Cited by 113
Speeckaert, R., Dugardin, J., Lambert, J., Lapeere, H., Verhaeghe, E., Speeckaert, M. M., & van Geel, N. (2018) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.14792 · Cited by 113
Developing core outcome set for vitiligo clinical trials: international e‐Delphi consensus
Eleftheriadou, V., Thomas, K. S., van Geel, N., Hamzavi, I. H., Lim, H. W., Suzuki, T., Katayama, I., Anbar, T. S., Abdallah, M., Benzekri, L., et al. (2015) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12354 · Cited by 111
Self-citationMembrane Lipid Alterations as a Possible Basis for Melanocyte Degeneration in Vitiligo
Dell’Anna, M. L., Ottaviani, M., Albanesi, V., Vidolin, A. P., Leone, G., Ferraro, C., Cossarizza, A., Rossi, L. C., & Picardo, M. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700700 · Cited by 111
Prevalence of Vitiligo and Associated Comorbidities in Korea
Lee, H., Lee, M., Lee, D., Kang, H. Y., Kim, K., Choi, G. S., Shin, J., Lee, H. J., Kim, D. H., Kim, T. H., et al. (2015) · Yonsei Medical Journal · doi:10.3349/ymj.2015.56.3.719 · Cited by 111
The prevalence and odds of depression in patients with vitiligo: a meta‐analysis
Wang, G., Qiu, D., Yang, H., & Liu, W. (2017) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.14739 · Cited by 111
Simvastatin Prevents and Reverses Depigmentation in a Mouse Model of Vitiligo
Agarwal, P., Rashighi, M., Essien, K. I., Richmond, J. M., Randall, L. M., Pazoki–Toroudi, H., Hunter, C. A., & Harris, J. E. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.529 · Cited by 110
Functional defects of peripheral regulatory T lymphocytes in patients with progressive vitiligo
Ahmed, M. B., Zarâa, I., Rekik, R., Elbeldi-Ferchiou, A., Kourda, N., Hmida, N. B., Abdeladhim, M., Karoui, O., Osman, A. B., Mokni, M., et al. (2011) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2011.00920.x · Cited by 109
Wu, J. H., & COHEN, B. A. (2019) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000792 · Cited by 109
Dermoscopy in vitiligo: diagnosis and beyond
Jha, A. K., Sonthalia, S., Lallas, A., & Chaudhary, R. K. P. (2017) · International Journal of Dermatology · doi:10.1111/ijd.13795 · Cited by 106
The Problems in Sexual Functions of Vitiligo and Chronic Urticaria Patients
Sukan, M., & Maner, F. (2006) · Journal of Sex & Marital Therapy · doi:10.1080/00926230600998482 · Cited by 105
Epidemiology of vitiligo in the French West Indies (Isle of Martinique)
Boisseau‐Garsaud, A., Garsaud, P., Calès-Quist, D., et al. (2000) · International Journal of Dermatology · doi:10.1046/j.1365-4362.2000.00880.x · Cited by 105
Common variants in FOXP1 are associated with generalized vitiligo
Jin, Y., Birlea, S. A., Fain, P. R., Mailloux, C. M., Riccardi, S. L., Gowan, K., Holland, P. J., Bennett, D. C., Wallace, M. R., McCormack, W. T., et al. (2010) · Nature Genetics · doi:10.1038/ng.602 · Cited by 105
Self-citationvan Geel, N., Mollet, I. G., Schepper, S. D., Tjin, E. P. M., Vermaelen, K. Y., Clark, R. A., Kupper, T. S., Luiten, R. M., & Lambert, J. (2010) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2010.00703.x · Cited by 104
Ginkgo biloba for the treatment of vitilgo vulgaris: an open label pilot clinical trial
Szczurko, O., Shear, N. H., Taddio, A., & Boon, H. S. (2011) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-11-21 · Cited by 104
van Geel, N., Wallaeys, E., Goh, B. K., et al. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.10014.x · Cited by 104
Shared Genetic Relationships Underlying Generalized Vitiligo and Autoimmune Thyroid Disease
Spritz, R. A. (2010) · Thyroid · doi:10.1089/thy.2010.1643 · Cited by 103
Evidence-based management of vitiligo: summary of a Cochrane systematic review
Whitton, M. E., Pinart, M., Batchelor, J., et al. (2015) · British Journal of Dermatology · doi:10.1111/bjd.14356 · Cited by 103
Depigmentation therapies for normal skin in vitiligo universalis
AlGhamdi, K. M., & Kumar, A. (2010) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2010.03876.x · Cited by 102
Tumour necrosis factor-α inhibition can stabilize disease in progressive vitiligo
Webb, K. C., Tung, R. C., Winterfield, L. S., Gottlieb, A. B., Eby, J. M., Henning, S., & Poole, I. C. L. (2015) · British Journal of Dermatology · doi:10.1111/bjd.14016 · Cited by 102
The Efficacy of Afamelanotide and Narrowband UV-B Phototherapy for Repigmentation of Vitiligo
Grimes, P. E., Hamzavi, I. H., Lebwohl, M., Ortonne, J. P., & Lim, H. W. (2012) · JAMA Dermatology · doi:10.1001/2013.jamadermatol.386 · Cited by 102
Spritz, R. A. (2010) · Genome Medicine · doi:10.1186/gm199 · Cited by 102
Alterations of Mitochondria in Peripheral Blood Mononuclear Cells of Vitiligo Patients
Dell’Anna, M. L., Urbanelli, S., Mastrofrancesco, A., Camera, E., Iacovelli, P., Leone, G., Manini, P., d’Ischia, M., & Picardo, M. (2003) · Pigment Cell Research · doi:10.1034/j.1600-0749.2003.00087.x · Cited by 101
Optimal weekly frequency of 308-nm excimer laser treatment in vitiligo patients
Hofer, A., Hassan, A. S., Legat, F. J., et al. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2004.06321.x · Cited by 100
In Vitro Growth Characteristics of Melanocytes Obtained From Adult Normal and Vitiligo Subjects
Puri, N., Mojamdar, M. V., & Ramaiah, A. (1987) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12469795 · Cited by 98
TRPM2 mediates mitochondria-dependent apoptosis of melanocytes under oxidative stress
Kang, P., Zhang, W., Chen, X., Yi, X., Song, P., Chang, Y., Zhang, S., Gao, T., Li, C., & Li, S. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.08.022 · Cited by 96
Kemp, E. H., Gawkrodger, D. J., Watson, P. F., et al. (1997) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1997.4781381.x · Cited by 94
Genetic Variation of Promoter Sequence Modulates XBP1 Expression and Genetic Risk for Vitiligo
Ren, Y., Yang, S., Xu, S., Gao, M., Huang, W., Gao, T., Fang, Q., Quan, C., Zhang, C., Sun, L., et al. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000523 · Cited by 94
Vitiligo - Part 2 - classification, histopathology and treatment
Faria, A. R., Tarlé, R. G., Dellatorre, G., Mira, M. T., & de Castro, C. C. S. (2014) · Anais Brasileiros de Dermatologia · doi:10.1590/abd1806-4841.20142717 · Cited by 94
Singh, H., Kumaran, M. S., Bains, A., et al. (2015) · Dermatology · doi:10.1159/000433424 · Cited by 93
A Practical Approach to the Diagnosis and Treatment of Vitiligo in Children
Ezzedine, K., & Silverberg, N. B. (2016) · PEDIATRICS · doi:10.1542/peds.2015-4126 · Cited by 92
Self-citationBudania, A., Parsad, D., Kanwar, A. J., & Dogra, S. (2012) · British Journal of Dermatology · doi:10.1111/bjd.12007 · Cited by 91
CXCR3 Depleting Antibodies Prevent and Reverse Vitiligo in Mice
Richmond, J. M., Masterjohn, E., Chu, R., Tedstone, J., Youd, M. E., & Harris, J. E. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.10.048 · Cited by 91
Clinical significance of Koebner phenomenon in vitiligo
van Geel, N., Speeckaert, R., Wolf, J. D., et al. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.11158.x · Cited by 90
Anbar, T. S., Westerhof, W., Abdel‐Rahman, A. T., Ewis, A. A., & El‐Khayyat, M. (2008) · Photodermatology Photoimmunology & Photomedicine · doi:10.1111/j.1600-0781.2008.00385.x · Cited by 89
Betterle, C., Caretto, A., Zio, A. D., et al. (2009) · Dermatologica · doi:10.1159/000249466 · Cited by 89
Ezzedine, K., Gauthier, Y., Léauté-Labrèze, C., et al. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.08.031 · Cited by 89
Self-citationModern vitiligo genetics sheds new light on an ancient disease
Spritz, R. A. (2013) · The Journal of Dermatology · doi:10.1111/1346-8138.12147 · Cited by 87
Interfering with the IFN-γ/CXCL10 pathway to develop new targeted treatments for vitiligo.
Rashighi, M., & Harris, J. E. (2015) · PubMed · doi:10.3978/j.issn.2305-5839.2015.11.36 · Cited by 86
Current aspects of vitiligo genetics
Czajkowski, R., & Męcińska‐Jundziłł, K. (2014) · Advances in Dermatology and Allergology · doi:10.5114/pdia.2014.43497 · Cited by 85
Histopathologic Features in Vitiligo
Kim, Y. C., Kim, Y. J., Kang, H. Y., Sohn, S., & Lee, E. (2008) · American Journal of Dermatopathology · doi:10.1097/dad.0b013e3181651511 · Cited by 84
Response of Vitiligo to Narrowband Ultraviolet B and Oral Antioxidants
Elgoweini, M., & Din, N. M. N. E. (2009) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009335769 · Cited by 84
Confetti-like depigmentation: A potential sign of rapidly progressing vitiligo
Sosa, J. J., Currimbhoy, S. D., Ukoha, U. T., et al. (2015) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.05.014 · Cited by 83
CCL22 to Activate Treg Migration and Suppress Depigmentation in Vitiligo
Eby, J. M., Kang, H.-K., Tully, S. T., Bindeman, W. E., Peiffer, D. S., Chatterjee, S., Mehrotra, S., & Poole, I. C. L. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.26 · Cited by 83
A central role for inducible heat‐shock protein 70 in autoimmune vitiligo
Mosenson, J. A., Eby, J. M., Hernandez, C., & Poole, I. C. L. (2013) · Experimental Dermatology · doi:10.1111/exd.12183 · Cited by 83
Eleftheriadou, V., Thomas, K. S., Whitton, M. E., Batchelor, J., & Ravenscroft, J. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.11056.x · Cited by 83
Vitiligo prevalence study in Shaanxi Province, China
Lu, T., Gao, T., Wang, A., et al. (2006) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2006.02848.x · Cited by 83
Ibrahim, Z. A., El-Ashmawy, A. A., El‐Tatawy, R. A., & Sallam, F. A. A. (2015) · Journal of Cosmetic Dermatology · doi:10.1111/jocd.12194 · Cited by 83
Dell’Anna, M. L., Ottaviani, M., Bellei, B., Albanesi, V., Cossarizza, A., Rossi, L. C., & Picardo, M. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22027 · Cited by 82
New insights in segmental vitiligo: case report and review of theories
van Geel, N., Mollet, I. G., Brochez, L., Dutré, M., Schepper, S. D., Verhaeghe, E., Lambert, J., & Speeckaert, R. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10650.x · Cited by 81
Evaluation of safety and efficacy of topical prostaglandin E2in treatment of vitiligo
Kapoor, R., Phiske, M. M., & Jerajani, H. R. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08923.x · Cited by 80
Brazzelli, V., Antoninetti, M., Palazzini, S., et al. (2007) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2007.02278.x · Cited by 79
Preliminary evaluation of vitiligo using in vivo reflectance confocal microscopy
Ardigò, M., Malizewsky, I., Dell’Anna, M. L., Berardesca, E., & Picardo, M. (2007) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2007.02275.x · Cited by 79
Erbium:YAG Laser and Cultured Epidermis in the Surgical Therapy of Stable Vitiligo
Guerra, L., Primavera, G., Raskovic, D., et al. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.10.1303 · Cited by 79
Ezzedine, K., Diallo, A., Léauté-Labrèze, C., et al. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.11002.x · Cited by 78
Self-citationLiving with vitiligo: results from a national survey indicate differences between skin phototypes
Ezzedine, K., Grimes, P. E., Meurant, J. ‐., Sénéschal, J., Léauté-Labrèze, C., Ballanger, F., Jouary, T., TAIEB, C., & Taı̈eb, A. (2015) · British Journal of Dermatology · doi:10.1111/bjd.13839 · Cited by 78
Self-citationA Romanian Population Isolate With High Frequency of Vitiligo and Associated Autoimmune Diseases
Birlea, S. A., Fain, P. R., & Spritz, R. A. (2008) · Archives of Dermatology · doi:10.1001/archderm.144.3.310 · Cited by 78
Mina, M., Elgarhy, L. H., Al‐saeid, H., et al. (2018) · Journal of Cosmetic Dermatology · doi:10.1111/jocd.12440 · Cited by 78
Ezzedine, K., Whitton, M. E., & Pinart, M. (2016) · JAMA · doi:10.1001/jama.2016.12399 · Cited by 78
Self-citationSurgical treatment of vitiligo: why, when and how
Falabella, R. (2003) · Journal of the European Academy of Dermatology and Venereology · doi:10.1046/j.1468-3083.2003.00718.x · Cited by 77
Abdelghani, R., Ahmed, N. A., & Darwish, H. M. A. (2017) · Journal of Cosmetic Dermatology · doi:10.1111/jocd.12397 · Cited by 77
Why treatments do(n't) work in vitiligo: An autoinflammatory perspective
Speeckaert, R., Speeckaert, M. M., & van Geel, N. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.12.003 · Cited by 76
Clinical and histopathologic characteristics of trichrome vitiligo
Hann, S. K., Kim, Y. S., Yoo, J. H., et al. (2000) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(00)90170-1 · Cited by 75
Nisticò, S. P., Chiricozzi, A., Saraceno, R., et al. (2011) · Photomedicine and Laser Surgery · doi:10.1089/pho.2011.3029 · Cited by 74
Sethi, S., Mahajan, B. B., Gupta, R. R., et al. (2007) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2007.03226.x · Cited by 74
Tenascin is overexpressed in vitiligo lesional skin and inhibits melanocyte adhesion
Poole, I. C. L., Wijngaard, R. M. J. G. V. D., Westerhof, W., et al. (1997) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1997.18011894.x · Cited by 74
Halo Nevi Association in Nonsegmental Vitiligo Affects Age at Onset and Depigmentation Pattern
Diallo, A. (2012) · Archives of Dermatology · doi:10.1001/archdermatol.2011.351 · Cited by 73
Batchelor, J., Tan, W., Tour, S. K., Yong, A., Montgomery, A. A., & Thomas, K. S. (2015) · British Journal of Dermatology · doi:10.1111/bjd.14208 · Cited by 72
The utility of dermoscopy in the diagnosis of evolving lesions of vitiligo
Thatte, S., & Khopkar, U. S. (2014) · Indian Journal of Dermatology Venereology and Leprology · doi:10.4103/0378-6323.144144 · Cited by 72
Clinical significance of Koebner’s phenomenon in vitiligo
van Geel, N., Speeckaert, R., Wolf, J. D., et al. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.11111.x · Cited by 71
400 cases of vitiligo. A clinico-therapeutic analysis.
Behl, P. N., & Bhatia, R. K. (1972) · PubMed · Cited by 70
Clinical markers of vitiligo activity
Benzekri, L., & Gauthier, Y. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.12.040 · Cited by 70
Quality of life in people with vitiligo: a systematic review and meta-analysis
Morrison, B., Burden-Teh, E., Batchelor, J. M., Mead, E., Grindlay, D., & Ratib, S. (2017) · British Journal of Dermatology · doi:10.1111/bjd.15933 · Cited by 70
Batçıoğlu, K., Ozturk, I., Karataş, F., Haznecı, E., & Genç, M. (2008) · Indian Journal of Dermatology · doi:10.4103/0019-5154.39577 · Cited by 69
Abdallah, M., El-Mofty, M. A., Anbar, T. S., Rasheed, H. M., Esmat, S. M., Al‐Tawdy, A., Fawzy, M. M., Abdel-Halim, D. M., Hegazy, R. A., Gawdat, H. I., et al. (2017) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12667 · Cited by 69
Lopes, C., Trevisani, V. F. M., & Melnik, T. (2015) · American Journal of Clinical Dermatology · doi:10.1007/s40257-015-0164-2 · Cited by 68
Taı̈eb, A., Morice‐Picard, F., Jouary, T., Ezzedine, K., Cario, M., & Gauthier, Y. (2008) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2008.00511.x · Cited by 68
Self-citationGuidelines for the diagnosis and treatment of vitiligo in Japan
Oiso, N., Suzuki, T., Wataya‐Kaneda, M., et al. (2013) · The Journal of Dermatology · doi:10.1111/1346-8138.12099 · Cited by 67
Reyes, E., Jaén, P., Heras, E. D. L., de Eusebio, E., Carrión, F., Cuevas, J., González, S., Villarrubia, V. G., & Álvarez‐Mon, M. (2006) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2005.12.006 · Cited by 67
Studies on vitiligo. II. Familial aggregation and genetics
Das, S., Majumder, P. P., Majumdar, T. K., Haldar, B., & Rao, D. C. (1985) · Genetic Epidemiology · doi:10.1002/gepi.1370020303 · Cited by 66
Follicular vitiligo: A report of 8 cases
Gan, E. Y., Cario, M., Pain, C., Goussot, J., Taïeb, A., Sénéschal, J., & Ezzedine, K. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.12.049 · Cited by 65
Self-citationSanclemente, G., García, J. G., Tobón, J. J. Z., et al. (2008) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2008.02839.x · Cited by 64
Personal Responses of Patients to Vitiligo
Porter, J. R. (1978) · Archives of Dermatology · doi:10.1001/archderm.1978.01640210075025 · Cited by 64
Vitiligo impact scale: An instrument to assess the psychosocial burden of vitiligo
Ramam, M., Mehta, M., Sreenivas, V., Sharma, V., Khandpur, S., & Krishna, G. (2013) · Indian Journal of Dermatology Venereology and Leprology · doi:10.4103/0378-6323.107637 · Cited by 64
Prevalence and Clinical Profile of Vitiligo in China: A Community-based Study in Six Cities
Wang, X., Du, J., Wang, T., Zhou, C., Shen, Y., Ding, X., Tian, S., Liu, Y., Peng, G., Xue, S., et al. (2013) · Acta Dermato Venereologica · doi:10.2340/00015555-1397 · Cited by 64
Cited by
Dopamine, Immunity, and Disease
Channer, B., Matt, S. M., Nickoloff-Bybel, E. A., Pappa, V., Agarwal, Y., Wickman, J., & Gaskill, P. J. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000618 · Cited by 308
Janus Kinase Inhibitors in the Treatment of Vitiligo: A Review
Qi, F., Liu, F., & Gao, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.790125 · Cited by 203
Faraj, S., Kemp, E. H., & Gawkrodger, D. J. (2022) · Clinical and Experimental Immunology · doi:10.1093/cei/uxab002 · Cited by 94
Baicalein inhibits RLS3-induced ferroptosis in melanocytes
Yang, M., Li, X., Li, H., Zhang, X., Liu, X., & Song, Y. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.05.010 · Cited by 53
Eleftheriadou, V., Delattre, C., Chetty-Mhlanga, S., Lee, C., Girardat-Rotar, L., Khan, I., Mathew, A., & Thompson, A. R. (2024) · British Journal of Dermatology · doi:10.1093/bjd/ljae133 · Cited by 21
Metadata
- Authors
- Bergqvist, C., & Ezzedine, K.
- Affiliations
- Université Paris-Est Créteil (FR)
- Venue
- Dermatology
- Publisher
- S. Karger AG
- Published
- 2020
- Volume
- 236
- Issue
- 6
- Pages
- 571-592
- ISSN
- 1018-8665 (ISSN-L)
- 1421-9832
- OpenAlex
- W3012531490
- Cited by
- 799
- References
- 270
- Citations by year
- 2026: 104 · 2025: 167 · 2024: 160 · 2023: 188 · 2022: 121 · 2021: 44 · 2020: 15
- FWCI
- 10.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Dermatology (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › melanin and skin pigmentation
- Health Sciences › Medicine › Dermatology › Hair Growth and Disorders
- Health Sciences › Medicine › Dermatology › Dermatologic Treatments and Research
- Keywords
- vitiligo, melanocyte loss, autoimmune disease, vitiligo pathogenesis, segmental vitiligo, non-segmental vitiligo, vitiligo classification, psychological burden, vitiligo treatment
- MeSH terms
- Humans, Quality of Life, Vitiligo, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.